561023-90-3

Basic information

• Product Name: 2-{4-[2-(1H-benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl}-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide
• Synonyms: 1-piperazineacetamide, 4-[2-(1H-benzimidazol-2-ylthio)ethyl]-N-[6-methyl-2,4-bis(methylthio)-3-pyridinyl]-; 2-{4-[2-(1H-Benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl}-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide
• CAS NO: 561023-90-3
• Molecular Formula: C₂₃H₃₀N₆OS₃
• Molecular Weight: 502.7189
• Mol File: 561023-90-3.mol

Chemical Properties

• Density: 1.371g/cm³
• Refractive Index: 1.708
• CAS DataBase Reference: 2-{4-[2-(1H-benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl}-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-{4-[2-(1H-benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl}-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide(561023-90-3)
• EPA Substance Registry System: 2-{4-[2-(1H-benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl}-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide(561023-90-3)

Safety Data

• Hazardous Substances Data: 561023-90-3(Hazardous Substances Data)

Upstream product

• 664340-58-3 2-(4-(2-hydroxyethyl)piperazin-1-yl)-N-(6-methyl-2,4-bis(methylthio)pyridin-3-yl)acetamide 
• 134991-79-0 3-amino-2,4-bis(methylthio)-6-methyl-pyridine 
• 217096-06-5 N-[2,4-bis(methylthio)-6-methylpyridin-3-yl]-2-bromoacetamide 
• 873205-89-1 N-[2,4-bis(methylthio)-6-methylpyridin-3-yl]-2-hydroxyacetamide 
• 217095-58-4 1-[2-(BENZIMIDAZOL-2-YL-THIO)ETHYL]PIPERAZINE 
• 134469-07-1 Benzimidazol-2-thiol 

Relevant articles and documents

Discovery of Clinical Candidate 2-(4-(2-((1 H-Benzo[ d]imidazol-2-yl)thio)ethyl)piperazin-1-yl)- N-(6-methyl-2,4-bis(methylthio)pyridin-3-yl)acetamide Hydrochloride [K-604], an Aqueous-Soluble Acyl-CoA:Cholesterol O-Acyltransferase-1 Inhibitor

2-(4-(2-((1H-Benzo[d]imidazol-2-yl)thio)ethyl)piperazin-1-yl)-N-(6-methyl-2,4-bis(methylthio)pyridin-3-yl)acetamide hydrochloride (K-604, 2) has been identified as an aqueous-soluble potent inhibitor of human acyl-coenzyme A:cholesterol O-acyltransferase

METHOD FOR PRODUCING CYCLIC DIAMINE DERIVATIVE

The present invention provides an industrially useful method for synthesizing a cyclic diamine derivative (4) or a salt thereof which serves as an ACAT inhibitor. A 2-hydroxyacetylaminopyridine compound represented by formula (1), and a method for produci

METHOD FOR PRODUCING CYCLIC DIAMINE DERIVATIVE OR SALT THEREOF

The present invention is directed to a method for producing a cyclic diamine compound (3) or a salt thereof through the following scheme: (wherein Ar represents a phenyl group, a pyridyl group, or a pyrimidinyl group, any of which may have a substituent; X represents NH, S, or O; ring A represents a benzene ring or a pyridine ring, which may have a substituent; 1 represents an integer of 1 or 2; m represents an integer of 1 or 2; and n represents an integer of 1 to 6). The method enables synthesis of a cyclic diamine compound (3) or a salt thereof, which serves as an ACAT inhibitor, in an industrially useful manner.

PROCESSES FOR PRODUCTION OF CYCLIC DIAMINE COMPOUNDS OR SALTS THEREOF

The present invention is directed to a process for producing cyclic diamine compounds(4) or salts or intermediates thereof according to the following reaction scheme: (wherein R is a protective group and Ar is an optionally substituted aryl group). According to the present invention, the cyclic diamine compounds (4) useful as drugs or salts or intermediates thereof can be produced at high levels of yield and purity in terms of industrially advantageous productivity.

Hydroxyalkyl cyclic diamine compound

The present invention is directed to a compound represented by the following formula (1) and to a process for producing a compound (5) from the compound (1). By use of the compound (1) of the present invention, a variety of cyclic diamine derivatives (5) or salts thereof, useful as drugs, can be produced in an industrially advantageous manner with a constant yield.